Furthermore, these TGF-β isoforms significantly inhibited ovarian cancer cell growth in a dose-dependent manner, which was in accordance with the inhibitory effect of TGF-β1 on NIH-OVCAR3 cells in previous studies [17,18]. This evidence concerns the gene TGFB1 and ovarian carcinoma.